The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular characterization and treatment patterns of lung cancer in solid organ transplant (SOT) recipients.
 
Athena Tsu
No Relationships to Disclose
 
Rama Al Hamed
No Relationships to Disclose
 
Benjamin Herzberg
Honoraria - Boxer Capital; Curio Science; DAVA Oncology; Eisai; IDEOlogy Health; IDEOlogy Health; Kyowa Kirin International; OncLive/MJH Life Sciences
Consulting or Advisory Role - Abbvie; Amgen; Arvinas; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Daiichi-Sankyo; IDEAYA Biosciences; Johnson and Johnson; Lilly; Revolution Medicines
Research Funding - Alterome Therapeutics (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); IDEAYA Biosciences (Inst); Lilly (Inst); Monte Rosa Therapeutics (Inst); Nested Therapeutics (Inst); Prelude Therapeutics (Inst); Repare Therapeutics (Inst); Revolution Medicines (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Arvinas; DAVA Oncology
 
Brian Henick
Honoraria - Cantor Fitzgerald; Guidepoint Inc
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Regeneron; Synthekine
Research Funding - Genentech/Roche (Inst); Johnson & Johnson/Janssen (Inst); NexImmune (Inst); Stand Up 2 Cancer (Inst); V Foundation (Inst)
 
Philippe Lemaitre
No Relationships to Disclose
 
Catherine Shu
Consulting or Advisory Role - AstraZeneca; EMD Serono; Genentech/Roche; Janssen
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Lanyi Chen
No Relationships to Disclose